Apogee Therapeutics' Eczema Drug Provides Rapid Itch Relief In Phase 2 Trial

benzinga.com/news/health-care/25/07/46271107/apogee-therapeutics-eczema-drug-provides-rapid-itch-relief-in-phase-2-trial

Apogee Therapeutics Inc. (NASDAQ:APGE) stock is experiencing a significant surge, trading almost 29% higher in premarket on Monday.
This substantial increase in stock price follows the release of positive 16-week data from Part A of the Phase 2 APEX clinical trial of APG777, an anti-IL-13…

This story appeared on benzinga.com, 2025-07-07 11:26:21.
The Entire Business World on a Single Page. Free to Use →